Harel Insurance Investments & Financial Services Ltd. Collegium Pharmaceutical, Inc Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.31 Billion
Q2 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$14.22 - $20.88 $28,397 - $41,697	-1,997 Closed	0 $0
Q1 2022 May 03, 2022	SELL	$17.2 - $22.5 $2,820 - $3,690	-164 Reduced 7.59%	1,997 $41,000
Q4 2021 Feb 07, 2022	BUY	$17.5 - $21.35 $12,967 - $15,820	741 Added 52.18%	2,161 $42,000
Q3 2021 Oct 25, 2021	BUY	$17.75 - $25.39 $25,205 - $36,053	1,420 New	1,420 $28,000

Others Institutions Holding COLL

# of Institutions

236

Shares Held

39.4M

Call Options Held

84.2K

Put Options Held

18.6K

Black Rock Inc. New York, NY

5.79M
Shares

$222 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

3.41M
Shares

$130 Million
0.28% of portfolio
Eventide Asset Management, LLC Boston, MA

2.63M
Shares

$101 Million
1.49% of portfolio
Vanguard Group Inc Valley Forge, PA

2.37M
Shares

$90.7 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

2.33M
Shares

$89.3 Million
2.23% of portfolio

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.31B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account